Source: iQoncept / Shutterstock
Tenax Therapeutics (NASDAQ:TENX) recently unveiled its performance for the fourth quarter of 2023.
- The company reported earnings per share of -$11.84, falling short of the projected EPS of -$8.14.
- No revenue was reported by Tenax Therapeutics during the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tenx-stock-earnings-tenax-therapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
